ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Energy Infrastructure
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Modern Alpha
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Disruptive Technology Channel
  2. Eye DNA Synthesis Advances in an Active Biotech ETF
Disruptive Technology Channel
Share

Eye DNA Synthesis Advances in an Active Biotech ETF

Nick Peters-GoldenFeb 01, 2023
2023-02-01

It’s hard to imagine it now, but at the turn of the millennium, the big advancement in technology was not the latest phone app, it was the Human Genome Project. Since then, genetics advancements are now powering health and biotech industries, with the latest upgrades coming in DNA synthesis. A recent paper highlights the ability to create custom-designed DNA sequences, bolstering the case for an active biotech ETF like the ARK Genomic Revolution ETF (ARKG A-).

Developed in the 1970s, so-called de novo DNA synthesis creates whole new strands of DNA without the use of a template, enabling the creation of new drugs and the performance of basic research, according to ARK Invest. As such, de novo DNA synthesis is a critical part of research into genetics and its uses.

That’s why a new paper published in Nature Reviews Chemistry merits attention. The piece and its research highlight how the current use of DNA-based capabilities has resulted in a “virtuous cycle” that has spurred demand for DNA sequencing and, in turn, cost declines for DNA synthesis that should enable even more powerful synthesis moving forward.

The active biotech ETF ARKG and its focus on disruptive innovation in the space present it as a major option to consider for those convinced by the potential of advances in DNA synthesis. ARKG seeks out firms that could benefit from such advancements in areas like gene editing, genetic therapy, molecular diagnostics, and more.

Charging 75 basis points, ARKG has outperformed its ETF Database category average and its FactSet segment average over the last one month, with its returns of 19.4% significantly outpacing the averages’ respective returns of 4.8% and 9% over the last month. ARKG holds Cologuard makers Exact Sciences Corporation (EXAS) as its highest-weighted stock at 11.7%, double the next-highest weight, Pacific Biosciences of California (PACB), at 5.7%.

Biotech and genetics offer investors a tech space with the benefit of ties to a defensive area in healthcare. Add that into the fundamental promise of advancements in genetics, and an active biotech ETF like ARKG can be a strategy to consider this year.

For more news, information, and analysis, visit our Disruptive Technology Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X